Intrinsiqq
ProtoKinetix, Inc. logo

ProtoKinetix, Inc. Quality Score

PKTX

Compare
Quality10

Business quality is mixed (avg 50/100). Limited dimensions available for this sector.

Broad-market heuristics · Not a buy/sell signal

Business Quality & Capital Allocation

Share Dilution
0/100
335.9%

Heavy dilution above 5%

Capital Structure
100/100
-$524

Net cash position, no leverage concern

2011
$4512
$0.00
2012
$2406
$0.00
2013
$3065
$0.00
2014
$317
$147250
TTM
$524
$0.00
CashDebt
Customize WeightsPremiumUpgrade

ProtoKinetix (PKTX) quality: score, margins and returns

ProtoKinetix (PKTX) scores 10/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 2 metrics each scored 0 to 100. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is ProtoKinetix (PKTX) a high-quality business?+

ProtoKinetix scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 2 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does ProtoKinetix's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from PKTX's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where ProtoKinetix scores well and where it falls behind.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 4 Nov 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 5 Nov 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Pharmaceutical Preparations · Pick stocks to compare with PKTX

CompareIntrinsic value
CLNNClene Inc.
$3.44-1.86%15
ZOMDFZomedica Corp.
$0.08-3.49%46
SMNRSemnur Pharmaceuticals, Inc.
$0.15-40.00%0
NATRNature's Sunshine Products Inc.
$10.19+0.20%68
LFCRLifecore Biomedical, Inc.
$6.39+0.31%21
QTTBQ32 Bio Inc.
$8.34-1.65%60
LYELLyell Immunopharma, Inc.
$13.80+1.62%10
OPKOpko Health Inc.
$1.57-2.48%28

Spot a number that looks wrong? Check it in PKTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PKTX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.